In the KRAS-mutant LUAD setting, Id1 expression, known to provide an aggressive pro-oncogenic phenotype and to enhance the colonization capacity of lung cancer cells, has been shown to correlate with reduced overall survival and poor treatment response [22–24]. This evidence concerns the gene KRAS and lung carcinoma.